Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
1.92M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
888K
-
Shares change
-
+888K
-
Total reported value, excl. options
-
$5.1M
-
Value change
-
+$5.1M
-
Number of buys
-
23
-
Price
-
$5.77
Significant Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q2 2025
23 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q2 2025.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 888K shares
of 1.92M outstanding shares and own 46.27% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (176K shares), TANG CAPITAL MANAGEMENT LLC (167K shares), Sofinnova Investments, Inc. (138K shares), Pivotal bioVenture Partners Investment Advisor LLC (94.6K shares), VANGUARD GROUP INC (58.5K shares), Nan Fung Group Holdings Ltd (58.3K shares), SAMSARA BIOCAPITAL, LLC (52.5K shares), Board of Trustees of The Leland Stanford Junior University (36K shares), Pfizer Inc (31.3K shares), and GEODE CAPITAL MANAGEMENT, LLC (18.5K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.